These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction. Martinez-Ojeda J; Martinez-Toro J Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI. Otterstad JE; Brosstad F Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241 [No Abstract] [Full Text] [Related]
5. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4). Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ; Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312 [TBL] [Abstract][Full Text] [Related]
6. Primary angioplasty for acute myocardial infarction. Gordon PC Med Health R I; 2001 Feb; 84(2):44-50. PubMed ID: 11272659 [No Abstract] [Full Text] [Related]
7. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Huber K; De Caterina R; Kristensen SD; Verheugt FW; Montalescot G; Maestro LB; Van de Werf F; Eur Heart J; 2005 Oct; 26(19):2063-74. PubMed ID: 16055497 [No Abstract] [Full Text] [Related]
8. [Glycoprotein IIb/IIIa receptor antagonists for improving thrombolytic and interventional therapy in patients with acute myocardial infarct]. Zeymer U; Neuhaus KL Dtsch Med Wochenschr; 2000 Oct; 125(43):1297-300. PubMed ID: 11098229 [No Abstract] [Full Text] [Related]
9. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction. Joseph A J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258 [No Abstract] [Full Text] [Related]
10. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials. Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297 [TBL] [Abstract][Full Text] [Related]
11. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results. Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054 [TBL] [Abstract][Full Text] [Related]
13. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846 [TBL] [Abstract][Full Text] [Related]
14. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Antman EM; Van de Werf F Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037 [No Abstract] [Full Text] [Related]
16. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction. van den Brand M; Ronner EF Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877 [No Abstract] [Full Text] [Related]
17. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Antman EM Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302 [TBL] [Abstract][Full Text] [Related]
18. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194 [TBL] [Abstract][Full Text] [Related]
19. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study]. Franzosi MG Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828 [No Abstract] [Full Text] [Related]
20. New trials and therapies for acute myocardial infarction. Gumina RJ Med Clin North Am; 2007 Jul; 91(4):729-49; xii. PubMed ID: 17640545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]